Literature DB >> 3343999

Purification of two Leishmania donovani membrane proteins recognized by sera from patients with visceral leishmaniasis.

C L Jaffe1, M Zalis.   

Abstract

Two Leishmania donovani membrane proteins recognized by sera from patients with visceral leishmaniasis were purified using species-specific monoclonal antibodies and characterized. The molecular weights of the proteins, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, were approximately 70,000 and approximately 72,000, respectively. The 70 kDa protein, which appears as a diffuse band on silver staining, was resolved into a doublet by Western blotting with monoclonal antibody. Though of similar molecular weight and amino acid composition, the two proteins were shown to be distinct by peptide mapping and Western blotting of the purified material. The two proteins are recognized specifically by human visceral leishmaniasis serum and not by serum from cutaneous leishmaniasis or Chagas' disease. These proteins will be useful in developing a direct serodiagnostic assay for visceral leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3343999     DOI: 10.1016/0166-6851(88)90024-2

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  16 in total

1.  Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis.

Authors:  E Ghedin; W W Zhang; H Charest; S Sundar; R T Kenney; G Matlashewski
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Diagnostic and prognostic potential of a competitive enzyme-linked immunosorbent assay for leishmaniasis in India.

Authors:  M Chatterjee; C L Jaffe; S Sundar; D Basu; S Sen; C Mandal
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

3.  Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy.

Authors:  K Anam; F Afrin; D Banerjee; N Pramanik; S K Guha; R P Goswami; S K Saha; N Ali
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Monoclonal antibody affinity purification of a 78 kDa membrane protein of Leishmania donovani of Indian origin and its role in host-parasite interaction.

Authors:  Mandira Mukherjee; Anindita Bhattacharyya; Swadesh Duttagupta
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

5.  Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis.

Authors:  Promod Kumar; Kalpana Pai; Kiran Tripathi; H P Pandey; Shyam Sundar
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

6.  Identification of leishmanial antigens in the sera of patients with American visceral leishmaniasis.

Authors:  T G Evans; R D Pearson
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

7.  Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).

Authors:  E L Malchiodi; M G Chiaramonte; N J Taranto; N W Zwirner; R A Margni
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

8.  Purification and characterization of an 80-kilodalton membrane protein from Leishmania donovani.

Authors:  A C White; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

9.  The heterogeneity of Leishmania cell-surface antigens.

Authors:  A G Hernández; G Payares; A Misle; F Dagger
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

10.  Identification of an immunodominant 32-kilodalton membrane protein of Leishmania donovani infantum promastigotes suitable for specific diagnosis of Mediterranean visceral leishmaniasis.

Authors:  F Tebourski; A el Gaied; H Louzir; R Ben Ismail; R Kammoun; K Dellagi
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.